X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
male (27) 27
peripheral vascular disease (24) 24
index medicus (22) 22
adult (18) 18
animals (18) 18
hypertension (18) 18
female (17) 17
middle aged (17) 17
blood pressure - drug effects (15) 15
rats (13) 13
blood pressure (12) 12
hypertension - drug therapy (12) 12
renin (12) 12
renin - blood (12) 12
aged (9) 9
endocrinology & metabolism (9) 9
fumarates - therapeutic use (9) 9
antihypertensive agents - therapeutic use (8) 8
double-blind method (8) 8
hypertension - blood (8) 8
peptides (8) 8
renin-angiotensin system (8) 8
angiotensin (7) 7
dose-response relationship, drug (7) 7
plasma (7) 7
renin - antagonists & inhibitors (7) 7
renin - metabolism (7) 7
aldosterone (6) 6
aldosterone - blood (6) 6
angiotensin ii (6) 6
blood-pressure (6) 6
bradykinin (6) 6
heart rate - drug effects (6) 6
hypertension - physiopathology (6) 6
primary aldosteronism (6) 6
renin-angiotensin system - drug effects (6) 6
aliskiren (5) 5
amides (5) 5
amides - therapeutic use (5) 5
angiotensin-converting enzyme inhibitors - therapeutic use (5) 5
angiotensin-ii (5) 5
beer (5) 5
biochemistry (5) 5
cardiac & cardiovascular systems (5) 5
chemistry (5) 5
compositions or test papers therefor (5) 5
compositions thereof (5) 5
condition-responsive control in microbiological orenzymological processes (5) 5
culture media (5) 5
enzymology (5) 5
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (5) 5
fumarates - pharmacology (5) 5
general tagging of cross-sectional technologies spanning over several sections of the ipc (5) 5
general tagging of new technological developments (5) 5
inhibition (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
measuring (5) 5
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5) 5
metallurgy (5) 5
mice (5) 5
microbiology (5) 5
microorganisms or enzymes (5) 5
mutation or genetic engineering (5) 5
organic chemistry (5) 5
physics (5) 5
physiology (5) 5
processes of preparing such compositions (5) 5
processes using microorganisms (5) 5
propagating, preserving or maintaining microorganisms (5) 5
prorenin (5) 5
research (5) 5
risk factors (5) 5
spirits (5) 5
technical subjects covered by former uspc (5) 5
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (5) 5
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (5) 5
testing (5) 5
vinegar (5) 5
wine (5) 5
abridged index medicus (4) 4
angiotensin ii - metabolism (4) 4
antihypertensive agents - adverse effects (4) 4
antihypertensive agents - pharmacology (4) 4
blood pressure - physiology (4) 4
bradykinin - blood (4) 4
brain (4) 4
drug therapy (4) 4
expression (4) 4
fumarates - adverse effects (4) 4
immunohistochemistry (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
physiological aspects (4) 4
plasma renin activity (4) 4
rats, wistar (4) 4
renovascular hypertension (4) 4
system (4) 4
treatment outcome (4) 4
ace inhibitors (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the Renin-Angiotensin-Aldosterone System, ISSN 1470-3203, 03/2008, Volume 9
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 07/2017, Volume 390, Issue 10089, pp. 26 - 26
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)31468-X Byline: Franz H Messerli (a)(c)(d), Sripal... 
MEDICINE, GENERAL & INTERNAL | Angiotensin-Converting Enzyme Inhibitors | Humans | Cardiology | Medical colleges | ACE inhibitors | Cardiovascular disease | Ingredients | Pharmaceuticals
Journal Article
The Lancet, ISSN 0140-6736, 1998, Volume 351, Issue 9117, pp. 1693 - 1697
Bradykinin is believed to be the main mediator of symptoms in hereditary (HA) and acquired (AA) angio-oedema due to C1 esterase inhibitor deficiency, as well... 
MEDICINE, GENERAL & INTERNAL | KININS | HEREDITARY ANGIONEUROTIC-EDEMA | CONVERTING-ENZYME-INHIBITION | Angioedema - blood | Humans | Middle Aged | Adult | Female | Male | Aged | Bradykinin - blood | Chromatography, High Pressure Liquid | Radioimmunoassay - methods | Measurement | Physiological aspects | Kinins | Angioneurotic edema | Bradykinin | Peptides | Cardiovascular disease | Heredity
Journal Article
Journal Article
Annales d'Endocrinologie, ISSN 0003-4266, 07/2016, Volume 77, Issue 3, pp. 192 - 201
In patients with suspected primary aldosteronism (PA), the first diagnostic step, screening, must have high sensitivity and negative predictive value. The... 
Screening | Standard conditions | Aldosterone-to-renin ratio (ARR) | Renin | Primary aldosteronism | Aldosterone
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 10/2013, Volume 30, Issue 19, pp. 1638 - 1644
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 1/2010, Volume 30, Issue 1, pp. 130 - 139
Inflammatory mechanisms are known to contribute to the pathophysiology of traumatic brain injury (TBI). Since bradykinin is one of the first mediators... 
Neuroptotection | Kallikerin-kinin system | Brain edema | Inflammation | Traumatic brain injury | Bradykinin | brain edema | inflammation | bradykinin | Original | neuroptotection
Journal Article
Journal Article
Hypertension, ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity. We... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | plasma renin activity | DESIGN | ANTAGONIST | MYOCARDIAL-INFARCTION | EFFICACY | aliskiren | RISK FACTOR | ambulatory blood pressure measurement | SOCIETY | ALDOSTERONE SYSTEM | renin-angiotensin-aldosterone system | CARDIOVASCULAR-DISEASE | combination therapy | PERIPHERAL VASCULAR DISEASE | renin inhibitor | ESSENTIAL-HYPERTENSION | hypertension | INTERRUPTION | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 12/2013, Volume 34, Issue 45, pp. 3515 - 3524
Aims Aldosterone plays a crucial role in cardiovascular disease. 'Systemic' inhibition of its mineralocorticoid receptor (MR) decreases atherosclerosis by... 
Obesity | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | Mineralocorticoid receptor | INSULIN-RESISTANCE | Endothelial | Aldosterone | BLOCKADE | EPLERENONE | EXPRESSION | ADIPOSE-TISSUE | Basic Science
Journal Article
Hypertension: Journal of the American Heart Association, ISSN 0194-911X, 01/2002, Volume 39, Issue 1, pp. e1 - e8
Journal Article